Researchers at City of Hope are investigating the influence of hormone-mimicking chemicals during sensitive stage in women’s lives. Approximately 30 percent of breast cancers are diagnosed during menopause, a stage in life marked by a decline in the body’s production of estrogen and progestin. Growing evidence suggests it might also be a time when the breast is particularly susceptible